Rights and permissions
About this article
Cite this article
FDA turning a blind eye to off-label drug use?. Inpharma Wkly. 1634, 2 (2008). https://doi.org/10.2165/00128413-200816340-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200816340-00002